A Novel Mu-Conopeptide, Cniiic, Exerts Potent and Preferential Inhibition of Na(V) 1.2/1.4 Channels and Blocks Neuronal Nicotinic Acetylcholine Receptors.
Favreau, P., Benoit, E., Hocking, H.G., Carlier, L., D'Hoedt, D., Leipold, E., Markgraf, R., Schlumberger, S., Cordova, M.A., Gaertner, H., Paolini-Bertrand, M., Hartley, O., Tytgat, J., Heinemann, S.H., Bertrand, D., Boelens, R., Stocklin, R., Molgo, J.(2012) Br J Pharmacol 166: 1654
- PubMed: 22229737 
- DOI: 10.1111/j.1476-5381.2012.01837.x
- Primary Citation of Related Structures:  
2YEN - PubMed Abstract: 
The µ-conopeptide family is defined by its ability to block voltage-gated sodium channels (VGSCs), a property that can be used for the development of myorelaxants and analgesics. We characterized the pharmacology of a new µ-conopeptide (µ-CnIIIC) on a range of preparations and molecular targets to assess its potential as a myorelaxant ...